4.4 Letter

Novel treatments for epistaxis in hereditary hemorrhagic telangiectasia: a systematic review of the clinical experience with thalidomide

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output

Sophie Dupuis-Girod et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)

Review Pharmacology & Pharmacy

Long-Term Therapy With Thalidomide in Hereditary Hemorrhagic Telangiectasia: Case Report and Literature Review

Chih-Hsuan Chen et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2012)

Review Genetics & Heredity

Hereditary hemorrhagic telangiectasia: An overview of diagnosis, management, and pathogenesis

Jamie McDonald et al.

GENETICS IN MEDICINE (2011)

Article Pharmacology & Pharmacy

A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT)

Roberto Zarrabeitia et al.

CURRENT VASCULAR PHARMACOLOGY (2010)

Review Hematology

Hereditary hemorrhagic telangiectasia: from molecular biology to patient care

S. Dupuis-Girod et al.

JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2010)

Review Biochemistry & Molecular Biology

Hereditary haemorrhagic telangiectasia: a clinical and scientific review

Fatima S. Govani et al.

EUROPEAN JOURNAL OF HUMAN GENETICS (2009)

Article Medicine, Research & Experimental

The Effect of Bevacizumab (Avastin) Treatment on Epistaxis in Hereditary Hemorrhagic Telangiectasia

Jana Simonds et al.

LARYNGOSCOPE (2009)

Article Hematology

Hereditary haemorrhagic telangiectasia

A. A. Sharathkumar et al.

HAEMOPHILIA (2008)

Review Pharmacology & Pharmacy

Treatment of recurrent epistaxis in HHT

U. W. Geisthoff et al.

CURRENT PHARMACEUTICAL DESIGN (2006)

Article Medicine, Research & Experimental

Hormonal and antihormonal therapy for epistaxis in hereditary hemorrhagic telangiectasia

JJ Jameson et al.

LARYNGOSCOPE (2004)